IFITM3 and susceptibility to respiratory viral infections in the community

Autor: Tara C, Mills, Anna, Rautanen, Katherine S, Elliott, Tom, Parks, Vivek, Naranbhai, Margareta M, Ieven, Christopher C, Butler, Paul, Little, Theo, Verheij, Chris S, Garrard, Charles, Hinds, Herman, Goossens, Stephen, Chapman, Adrian V S, Hill

Publikováno v: The Journal of infectious diseases. 209(7)

Interferon-inducible transmembrane proteins 1, 2, and 3 (IFITM 1,2, and 3) are viral restriction factors that mediate cellular resistance to several viruses. We have genotyped a possible splice-site altering single-nucleotide polymorphism (rs12252) i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::43a1a1bf0f1d360356263f4ed00538ca
https://pubmed.ncbi.nlm.nih.gov/23997235

Human coronavirus HKU1 recognition of the TMPRSS2 host receptor.

Autor: McCallum M; Department of Biochemistry, University of Washington, Seattle, WA, USA., Park YJ; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Stewart C; Department of Biochemistry, University of Washington, Seattle, WA, USA., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Addetia A; Department of Biochemistry, University of Washington, Seattle, WA, USA., Brown J; Department of Biochemistry, University of Washington, Seattle, WA, USA., Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA., Gibson C; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Wong E; Vir Biotechnology, San Francisco, CA 94158, USA., Ieven M; Laboratory of Clinical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Telenti A; Vir Biotechnology, San Francisco, CA 94158, USA., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA. Electronic address: dveesler@uw.edu.

Publikováno v: Cell [Cell] 2024 Aug 08; Vol. 187 (16), pp. 4231-4245.e13. Date of Electronic Publication: 2024 Jul 03.

Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic.

Autor: van der Velden AW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Shanyinde M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Bongard E; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Böhmer F; Institute of General Practice, Rostock University Medical Center, Rostock, Germany., Chlabicz S; Department of Family Medicine, Medical University of Bialystok, Bialystok, Poland., Colliers A; Department of Family Medicine & Population Health, University of Antwerp, Antwerp, Belgium., García-Sangenís A; Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain., Malania L; National Center for Disease Control and Public Health, Tbilisi and Arner Science Management LLC, Tbilisi, Georgia., Pauer J; DRC Drug Research Centre, Balatonfüred, Hungary., Tomacinschii A; University Clinic of Primary Medical Assistance of State University of Medicine and Pharmacy 'N. Testemițanu', Chişinǎu, The Republic of Moldova., Yu LM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Loens K; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Ieven M; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Verheij TJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium., Vellinga A; School of Public Health, Physiotherapy and Sports Science, University College Dublin (UCD), Dublin, Ireland., Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Publikováno v: The European journal of general practice [Eur J Gen Pract] 2023 Dec; Vol. 29 (1), pp. 2270707. Date of Electronic Publication: 2023 Oct 23.

Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.

Autor: De Boeck I; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Cauwenberghs E; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Spacova I; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Gehrmann T; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Eilers T; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Delanghe L; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Wittouck S; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Bron PA; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium., Henkens T; Yun NV, Niel, Belgium., Gamgami I; Yun NV, Niel, Belgium., Simons A; Yun NV, Niel, Belgium., Claes I; Yun NV, Niel, Belgium., Mariën J; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Evolutionary Ecology Group, Department of Biology, University of Antwerpgrid.5284.b, Antwerp, Belgium., Ariën KK; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerpgrid.5284.b, Antwerp, Belgium., Bakokimi D; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Loens K; Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerpgrid.5284.b, Antwerp, Belgium.; Department of Microbiology, University Hospital Antwerp, Edegem, Belgium., Jacobs K; Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerpgrid.5284.b, Antwerp, Belgium., Ieven M; Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerpgrid.5284.b, Antwerp, Belgium.; Department of Microbiology, University Hospital Antwerp, Edegem, Belgium., Bruijning-Verhagen P; Julius Centre for Health Sciences and Primary Care, Department of Epidemiology, University Medical Centre Utrecht, Utrecht, The Netherlands., Delputte P; Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerpgrid.5284.b, Antwerp, Belgium., Coenen S; Family Medicine and Population Health (FAMPOP), University of Antwerpgrid.5284.b, Antwerp, Belgium.; Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerpgrid.5284.b, Antwerp, Belgium., Verhoeven V; Family Medicine and Population Health (FAMPOP), University of Antwerpgrid.5284.b, Antwerp, Belgium., Lebeer S; Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience Engineering, University of Antwerpgrid.5284.b, Antwerp, Belgium.

Publikováno v: Microbiology spectrum [Microbiol Spectr] 2022 Oct 26; Vol. 10 (5), pp. e0168222. Date of Electronic Publication: 2022 Sep 26.

Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections.

Autor: Sechan F; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Grobben M; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Edridge AWD; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Jebbink MF; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., Loens K; Department of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium.; Department of Microbiology, University Hospital Antwerp, Edegem, Belgium., Ieven M; Department of Microbiology, University Hospital Antwerp, Edegem, Belgium., Goossens H; Department of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium.; Department of Microbiology, University Hospital Antwerp, Edegem, Belgium., van Hemert-Glaubitz S; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands., van Gils MJ; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., van der Hoek L; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2022 Apr 27; Vol. 13, pp. 853410. Date of Electronic Publication: 2022 Apr 27 (Print Publication: 2022).